US Patent Issued to Mitchell Lynn Tate on Aug. 25 for "Treatment of pathogen infections formulations and methods for use" (Arizona Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,734, issued on Aug. 25, was assigned to Mitchell Lynn Tate (Surprise, Ariz.).

"Treatment of pathogen infections formulations and methods for use" was invented by Mitchell Lynn Tate (Surprise, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An oral product comprising nano-sized, heat tolerable, shelf stable peptides and enzymes. Once the peptides and enzymes are inside the body of a user, they dimerize the nucleic acids of viruses, bacteria and fungi. Thus, the peptides and enzymes are capable of inactivating the genome of pathogens, including without limitation, SARS-COV-2 and Influenza A/CA/04/2009 (H1N1) virus."

The patent was filed on Oct. ...